Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor

Genes Chromosomes and Cancer

Volumn 27, Issue 2, 2000, Pages 124-129

  Shafman, Timothy D ^a   Levitz, Seth ^b   Nixon, Asa J ^b   Gibans, Lor Anne ^a   Nichols, Kim E ^b   Bell, Daphne W ^b   Ishioka, Chikashi ^c   Isselbacher, Kurt J ^b   Gelman, Rebecca ^b   Garber, Judy ^b   Harris, Jay R ^a   Haber, Daniel A ^b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TOHOKU UNIVERSITY   (Japan)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; SECOND CANCER;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL CYCLE PROTEINS; COHORT STUDIES; DNA-BINDING PROTEINS; FEMALE; GERM-LINE MUTATION; HETEROZYGOTE DETECTION; HUMANS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PREVALENCE; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 19244380910     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200002)27:2<124::AID-GCC2>3.0.CO;2-M     Document Type: Article

References (32)

1. Athma P, Rappaport R, Swift M. 1996. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92:130-134.
2. Barlow C, Eckaus MA, Schaffer AA, Wynshaw-Boris A. 1999 Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat Genet 21:359-360.
3. Boice, JD, Miller RW. 1992. Risk of breast cancer in ataxia-telangiectasia. N Engl J Med 326:1357-1358.
4. Boice JD, Harvey EB, Blettner M, Stovall M, Flannery JT. 1992. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326:781-785.
5. Byrd PJ, McConville CM, Cooper P, Parkhill J, Stankovic T, McGuire GM, Thick JA, Taylor AMR. 1996. Mutations revealed by sequencing the 5′ half of the gene for ataxia telangiectasia. Hum Mol Genet 5:145-149.
6. Easton DF. 1994. Cancer risks in A-T heterozygotes. Internat J Rad Biol 66:177-182.
7. FitzGerald MG, Bean JM, Hegde SR, Unsal H, Mat-Donald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA. 1997. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15:307-310.
8. FitzGerald MG, Marsh DJ, Wahrer D, Bell D, Carun S, Shannon KE, Ishioka C, Isselbacher KJ, Garber JE, Eng C, Haber DA. 1998. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene 17:727-731.
9. Gilad S, Khosravi R, Shkedy D, Uziel T, Ziv Y, Savitsky K, Rotman G, Smith S, Chessa L, Jorgensen TJ, Harnik R, Frydman M, Sanal O, Portnoi S, Goldwicz Z, Jaspers NJG, Gatti RA, Lenoir G, Lavin MF, Tatsumi L, Wegner RD, Shiloh Y, Bar-Shira A. 1996. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 5:433-439.
10. Hall EJ, Geard CR, Brenner DJ. 1992. Risk of breast cancer in ataxia-telangiectasia. N Engl J Med 326:1358-1359.
11. Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. 1993. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol 11:1545-1552.
12. Hecht F, Hecht B. 1990. Cancer in ataxia telangiectasia patients. Cancer Genet Cytogenet 46:9-19.
13. Ishioka C, Suzuki T, FitzGerald M, Shimodaira H, Shimada A, Nomizu T, Haber D, Kanamaru R. 1997. Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc Nat Acad Sci USA 94:449-453.
14. Kelly CA, Wang XY, Chu JC, Hartsell WF. 1996. Dose to contralateral breast: a comparison of four primary breast irradiation techniques. Internat J Radiat Oncol, Biol Phys 34:727-732.
15. Land CE. 1992. Risk of breast cancer in ataxia-telangiectasia. N Engl J Med 326:1359-1360.
16. Nichols KE, Levitz S, Shannon K, Wahrer D, Bell DW, Chang G, Hegde S, Nenberg D, Shafman T, Tarbell NJ, Manch P, Ishioka C, Haber DA, Diller L. 1999. Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease. J Clin Oncol 17:1259-1266.
17. Pippard EC, Hall AJ, Barker DJ, Bridges BA. 1988. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48:2929-2932.
18. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SN, Lovett M, Collins FS, Shiloh Y. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
19. Sedgwick R, Broder E. 1991. Ataxia telangiectasia. In Yinkin PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology. New York: Elsevier Press.
20. Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ, Taylor AMR. 1998. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62:334-345.
21. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PAH, Taylor AMR. 1999. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353:26-29.
22. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James M, Lichter P, Dohner H. 1997. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 3:1155-1159.
23. Stine GJ. 1989. Population genetics. In The new human Genetics. Dubuque, IA: W.C. Brown, p 393-396.
24. Stoppa-Lyonnet D, Soulier J, Lauge A, Dastot H, Garand R, Sigaux F, Stern MH. 1998. Inactivation of the ATM gene in T-cell prolymphocytic leukemias. Blood 91:3920-3926.
25. Swift M, Reitnauer PJ, Morrell D, Ghase CL. 1987. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294.
26. Swift M, Morrell D, Massey RB, Chase CL. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1381-1386.
27. Taylor AM, Harnden DG, Arlett CF. 1975. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258:427-429.
28. Telatar M, Wang Z, Udar N, Liang T, Bernatowska-Matuszkiewicz E, Lavin M, Shiloh Y, Concannon P, Good RA, Gatti RA. 1996. Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening. Am J Hum Genet 59:40-44.
29. Telatar M. Teraoka S, Wang Z, Chun HH, Liang T, Castellvi-Bel S, Udar N, Borresen-Dale AL, Chessa L, Bernatowska-Matuszk-iewicz E, Porras O, Watanabe M, Junker A, Concannon P, Gatti RA. 1998. Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Am J Hum Genet 62:86-97.
30. Vorechovsky I, Rasio D, Liping L, Monaca C, Hammarstrom L, Webster ADB, Zaloudik J, Barbanti-Brodano G, James M, Russo G, Croce CM, Negrini M. 1996. The ATM gene and susceptibility to breast cancer: analysis of 38 breasat tumors reveals no evidence for mutation. Cancer Res 56:2726-2732.
31. Vorechovsky I Luo L, Dyer MJS, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarstrom L, Webster ADB, Yuille MAR. 1997. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet 17:96-99.
32. West CM, Elyan SA, Berry P, Cowan R, Scott D. 1995. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia. A-T and A-T heterozygotes. Int J Radiat Biol 68:197-203.